Your browser doesn't support javascript.
loading
A tool for evaluating heterogeneity in avidity of polyclonal antibodies.
Li, Kan; Dodds, Michael; Spreng, Rachel L; Abraha, Milite; Huntwork, Richard H C; Dahora, Lindsay C; Nyanhete, Tinashe; Dutta, Sheetij; Wille-Reece, Ulrike; Jongert, Erik; Ewer, Katie J; Hill, Adrian V S; Jin, Celina; Hill, Jennifer; Pollard, Andrew J; Munir Alam, S; Tomaras, Georgia D; Dennison, S Moses.
Afiliação
  • Li K; Center for Human Systems Immunology, Duke University, Durham, NC, United States.
  • Dodds M; Department of Surgery, Duke University, Durham, NC, United States.
  • Spreng RL; Integrated Drug Development, Certara, Seattle, WA, United States.
  • Abraha M; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.
  • Huntwork RHC; Center for Human Systems Immunology, Duke University, Durham, NC, United States.
  • Dahora LC; Department of Surgery, Duke University, Durham, NC, United States.
  • Nyanhete T; Center for Human Systems Immunology, Duke University, Durham, NC, United States.
  • Dutta S; Department of Surgery, Duke University, Durham, NC, United States.
  • Wille-Reece U; Center for Human Systems Immunology, Duke University, Durham, NC, United States.
  • Jongert E; Department of Immunology, Duke University, Durham, NC, United States.
  • Ewer KJ; Center for Human Systems Immunology, Duke University, Durham, NC, United States.
  • Hill AVS; Department of Immunology, Duke University, Durham, NC, United States.
  • Jin C; Structural Vaccinology Lab, Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
  • Hill J; PATH's Center for Vaccine Innovation and Access, Washington, DC, United States.
  • Pollard AJ; GSK Vaccines, Rixensart, Belgium.
  • Munir Alam S; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Tomaras GD; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Dennison SM; National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Center, Oxford, United Kingdom.
Front Immunol ; 14: 1049673, 2023.
Article em En | MEDLINE | ID: mdl-36875126
ABSTRACT
Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution tool (PAART) for use with label-free techniques, such as surface plasmon resonance and biolayer interferometry, that can monitor pAb-antigen interactions in real time to measure dissociation rate constant (kd ) for defining avidity. PAART utilizes a sum of exponentials model to fit the dissociation time-courses of pAb-antigens interactions and resolve multiple kd contributing to the overall dissociation. Each kd value of pAb dissociation resolved by PAART corresponds to a group of antibodies with similar avidity. PAART is designed to identify the minimum number of exponentials required to explain the dissociation course and guards against overfitting of data by parsimony selection of best model using Akaike information criterion. Validation of PAART was performed using binary mixtures of monoclonal antibodies of same specificity but differing in kd of the interaction with their epitope. We applied PAART to examine the heterogeneity in avidities of pAb from malaria and typhoid vaccinees, and individuals living with HIV-1 that naturally control the viral load. In many cases, two to three kd were dissected indicating the heterogeneity of pAb avidities. We showcase examples of affinity maturation of vaccine induced pAb responses at component level and enhanced resolution of heterogeneity in avidity when antigen-binding fragments (Fab) are used instead of polyclonal IgG antibodies. The utility of PAART can be manifold in examining circulating pAb characteristics and could inform vaccine strategies aimed to guide the host humoral immune response.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Humoral / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Humoral / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos